Kezar Life Sciences Stock Buy Hold or Sell Recommendation
| KZR Stock | USD 7.47 0.03 0.40% |
Considering the 90-day investment horizon and your slightly conservative level of risk, our recommendation regarding Kezar Life Sciences is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Kezar Life Sciences given historical horizon and risk tolerance towards Kezar Life. When Macroaxis issues a 'buy' or 'sell' recommendation for Kezar Life Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Kezar Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Kezar and provide practical buy, sell, or hold advice based on investors' constraints. Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Kezar |
Execute Kezar Life Buy or Sell Advice
The Kezar recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kezar Life Sciences. Macroaxis does not own or have any residual interests in Kezar Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kezar Life's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Kezar Life Trading Alerts and Improvement Suggestions
| Kezar Life Sciences had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 7 M. Reported Net Loss for the year was (101.87 M) with profit before taxes, overhead, and interest of 0. | |
| Kezar Life Sciences has about 306.84 M in cash with (81.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49. | |
| Kezar Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Christopher Kirk of 48950 shares of Kezar Life at 0.9 subject to Rule 16b-3 |
Kezar Life Returns Distribution Density
The distribution of Kezar Life's historical returns is an attempt to chart the uncertainty of Kezar Life's future price movements. The chart of the probability distribution of Kezar Life daily returns describes the distribution of returns around its average expected value. We use Kezar Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kezar Life returns is essential to provide solid investment advice for Kezar Life.
| Mean Return | 0.48 | Value At Risk | -4.39 | Potential Upside | 8.11 | Standard Deviation | 6.41 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kezar Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Kezar Stock Institutional Investors
The Kezar Life's institutional investors refer to entities that pool money to purchase Kezar Life's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Acuitas Investments, Llc | 2024-06-30 | 986.8 K | Ikarian Capital, Llc | 2024-06-30 | 869 K | Blackrock Inc | 2024-06-30 | 830.4 K | Qiming U.s. Ventures Management, Llc | 2024-06-30 | 828.7 K | Renaissance Technologies Corp | 2024-06-30 | 778.5 K | Millennium Management Llc | 2024-06-30 | 628.5 K | Jane Street Group Llc | 2024-06-30 | 549.1 K | Geode Capital Management, Llc | 2024-06-30 | 545.2 K | Citadel Advisors Llc | 2024-06-30 | 483.2 K | Suvretta Capital Management, Llc | 2024-06-30 | 7.2 M | Avidity Partners Management Lp | 2024-06-30 | 5 M |
Kezar Life Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | 21.0M | (56.3M) | (28.1M) | (89.8M) | 39.5M | 41.5M | |
| Change In Cash | (9.2M) | 6.3M | 41.7M | (22.4M) | (5.0M) | (4.7M) | |
| Free Cash Flow | (30.5M) | (37.1M) | (42.8M) | (60.4M) | (83.5M) | (79.3M) | |
| Depreciation | 1.3M | 1.5M | 1.5M | 1.0M | 1.1M | 1.0M | |
| Capital Expenditures | 607K | 194K | 316K | 1.6M | 1.8M | 1.9M | |
| Net Income | (35.1M) | (41.7M) | (54.6M) | (68.2M) | (101.9M) | (96.8M) | |
| End Period Cash Flow | 15.0M | 21.2M | 62.9M | 40.5M | 35.5M | 35.7M | |
| Change To Netincome | 4.0M | 4.9M | 7.6M | 14.0M | 16.1M | 16.9M | |
| Other Non Cash Items | (979K) | 317K | 91K | (1.2M) | (3.7M) | (3.9M) |
Kezar Life Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kezar Life or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kezar Life's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kezar stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.33 | |
β | Beta against Dow Jones | 1.15 | |
σ | Overall volatility | 6.41 | |
Ir | Information ratio | 0.06 |
Kezar Life Volatility Alert
Kezar Life Sciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kezar Life's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kezar Life's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Kezar Life Fundamentals Vs Peers
Comparing Kezar Life's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kezar Life's direct or indirect competition across all of the common fundamentals between Kezar Life and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kezar Life or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kezar Life's fundamental indicators could also be used in its relative valuation, which is a method of valuing Kezar Life by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Kezar Life to competition |
| Fundamentals | Kezar Life | Peer Average |
| Return On Equity | -0.51 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Operating Margin | (14.22) % | (5.51) % |
| Current Valuation | (76.75 M) | 16.62 B |
| Shares Outstanding | 7.3 M | 571.82 M |
| Shares Owned By Insiders | 14.79 % | 10.09 % |
| Shares Owned By Institutions | 63.90 % | 39.21 % |
| Number Of Shares Shorted | 177.96 K | 4.71 M |
| Price To Earning | (9.34) X | 28.72 X |
| Price To Book | 0.41 X | 9.51 X |
| Price To Sales | 7.82 X | 11.42 X |
| Revenue | 7 M | 9.43 B |
| EBITDA | (99.25 M) | 3.9 B |
| Net Income | (101.87 M) | 570.98 M |
| Cash And Equivalents | 306.84 M | 2.7 B |
| Cash Per Share | 4.49 X | 5.01 X |
| Total Debt | 18.93 M | 5.32 B |
| Debt To Equity | 0.04 % | 48.70 % |
| Current Ratio | 39.64 X | 2.16 X |
| Book Value Per Share | 25.77 X | 1.93 K |
| Cash Flow From Operations | (81.64 M) | 971.22 M |
| Short Ratio | 0.93 X | 4.00 X |
| Earnings Per Share | (13.12) X | 3.12 X |
| Target Price | 14.5 | |
| Number Of Employees | 58 | 18.84 K |
| Beta | 0.22 | -0.15 |
| Market Capitalization | 54.72 M | 19.03 B |
| Total Asset | 221.24 M | 29.47 B |
| Retained Earnings | (350.76 M) | 9.33 B |
| Working Capital | 189.21 M | 1.48 B |
| Current Asset | 74.47 M | 9.34 B |
| Current Liabilities | 2.18 M | 7.9 B |
| Net Asset | 221.24 M |
Note: Acquisition by Christopher Kirk of 48950 shares of Kezar Life at 0.9 subject to Rule 16b-3 [view details]
Kezar Life Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kezar . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 577.43 | |||
| Daily Balance Of Power | (0.14) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 7.5 | |||
| Day Typical Price | 7.49 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.03) |
About Kezar Life Buy or Sell Advice
When is the right time to buy or sell Kezar Life Sciences? Buying financial instruments such as Kezar Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kezar Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Business Supplies Thematic Idea Now
Business Supplies
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Supplies theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.